Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?

(1) Background: In recent years, “new” direct oral anticoagulants (DOAC) have gradually replaced other antithrombotic therapies. The international literature agrees on the increased mortality for traumatic brain injury (TBI) patients using vitamin K antagonists (VKA), but thus far, there are insuffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoni, Anna, Wedrich, Lukas, Schauperl, Martin, Höchtl-Lee, Leonard, Sigmund, Irene K., Gregori, Markus, Leitgeb, Johannes, Schwendenwein, Elisabeth, Hajdu, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658566/
https://www.ncbi.nlm.nih.gov/pubmed/36362496
http://dx.doi.org/10.3390/jcm11216268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658566/
https://www.ncbi.nlm.nih.gov/pubmed/36362496
http://dx.doi.org/10.3390/jcm11216268

Ejemplares similares